91AV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

POSTPONED: 3rd RSC / SCI / SEQT Symposium on Medicinal 91AV for Global Health

24 June 2020 14:00 - 26 June 2020 16:00, Tres Cantos, Spain


Introduction
Synopsis
Tuberculosis, malaria and diseases caused by a diverse range of pathogens, including flaviviruses (eg dengue, West Nile), kinetoplastids (causative agents of Chagas disease, leishmaniasis, etc) and gut pathogens (worms, bacteria, parasites), remain a cause of high mortality across the globe. Fortunately, an ever-improving understanding of the complex life-cycles of these disease-causing pathogens is presenting increasing opportunities for those seeking to tackle these global health problems.

This meeting will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health. Keynote talks from international experts from industry and academia, alongside perspectives detailing case histories in drug discovery, will highlight the latest developments in the field whilst also showcasing the opportunity for creativity and innovation. 

Who should attend?
Bringing together leading exponents for an exciting spread of themed sessions, the meeting will appeal to anyone with an interest in drug discovery and medicinal chemistry. And with great opportunities for collaborative academic-industrial partnerships and open innovation drug discovery programmes, researchers from both sectors will benefit from the networking opportunities that the meeting will also offer.

Call for Abstracts
Abstracts are invited for short oral presentations, and the final closing date for abstract submission is 24th April.  Early submission is encouraged because spaces are limited and speaker slots are being allocated on a case-by-case basis.

Registration, Fees and Bursaries
Registration is open with discounted rates for RSC, SCI and SEQT members and student members. 
Registration fees until 19th March:
£215 Member of the RSC, SCI or SEQT
£286 Non-member
£88 Student* member of RSC, SCI or SEQT (undergrad or post-grad)
£143 Student* non-member (undergrad or post-grad)

* Student is undergraduate or post-graduate, not post-doc, and does not apply to students in paid employment.
Member is paid-up member of the RSC, SCI or SEQT.

Students may also apply for bursaries funded by the RSC-BMCS and SCI to support registration, travel and accommodation costs.  

Exhibition
The exhibition will be situated in a single area just outside of the lecture theatre, ensuring excellent access to delegates throughout the meeting.  The exhibition charge of £1,320 includes:
- one full delegate's attendance
- logo in rolling slides and delegate handbook
- single promotional page in printed delegate handbook
Delegate pack inserts may be booked at £200 - no more than two sheets of A4 fixed together.

Sponsorship
Sponsors are encouraged to support this established event. Sponsorship will support the low registration fees being offered to students.   We are grateful to GlaxoSmithKline for their generous support of this symposium.

Venue and Travel
Address: Trelegy Auditorium, GlaxoSmithKline, Technology Park of Madrid, C / Severo Ochoa 2, 28760 - Tres Cantos, Madrid, Spain
Air: Madrid airport (Adolfo Suárez Madrid-Barajas) has a railway station at Terminal 4. A free shuttle bus runs from outside Terminals 1, 2 and 3 to Terminal 4.
Rail: Airport to Tres Cantos with one change at Chamartin station: less than 1 hour. Airport to Madrid Atocha central railway station: 25 minutes. Service provider is Renfe Cercanías.  
Taxi: Airport to Tres Cantos costs about €50: 30 minutes.

Accommodation
Discounted rates have been negotiated with two hotels in Tres Cantos, and further information may be found on our website..
Speakers
Venue
GlaxoSmithKline

Trelegy Auditorium, GlaxoSmithKline, Technology Park of Madrid, C / Severo Ochoa 2, Tres Cantos, 28760, Spain

Useful links

Committee
  • David Alker Independent Consultant, United Kingdom
  • Mónica Cacho-Izquierdo GlaxoSmithKline, Spain
  • Félix Calderón GlaxoSmithKline, Spain
  • Liam Cox University of Birmingham, United Kingdom
  • José Fiandor GlaxoSmithKline, Spain
  • Caroline Low (chair) Independent Consultant, United Kingdom
  • Maria Marco-Martin GlaxoSmithKline, Spain
  • Ana Rosa Merino-Nieto GlaxoSmithKline, Spain
  • Cristina Ramos GlaxoSmithKline, Spain
  • Andrew Stachulski University of Liverpool, United Kingdom

Organised by
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*